Title: Revised SPC: Lyumjev (insulin lispro) – all products

Paediatric data, showing pharmacokinetic differences between Lyumjev and Humalog similar to that seen in adults have been added to SPC but no recommendation on posology can be made. Also SPC now states no differences in safety/effectiveness with use in elderly & younger patients.

Source:

electronic Medicines compendium